Pharma & Biotech
You will receive alerts when there are new announcements on Zelira Therapeutics Ltd
Only registered members can use this feature.
Zelira Therapeutics Ltd (ASX:ZLD) is a medicinal cannabis company focused on first-in-class human clinical trials for insomnia, autism and opioid reduction
The global therapeutic medicinal cannabis company owns a portfolio of proprietary products positioned to enter global markets from 2020.
© Proactive Investors 2019.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.